NASDAQ:GBT

Global Blood Therapeutics - GBT Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Compare

Today's Range: $68.49
▼
$68.49
50-Day Range: $68.07
▼
$68.49
52-Week Range: $21.65
▼
$73.02

Volume: 74 shs
Average Volume: 2.07 million shs
Market Capitalization: $4.62 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $67.75

Institutional Ownership

Earnings Per Share Revenue

GBT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GBT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Global Blood Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	5	($1.28)	($0.74)	($1.01)
Q2 2023	5	($1.31)	($0.61)	($0.96)
Q3 2023	5	($1.36)	($0.37)	($0.88)
Q4 2023	5	($0.96)	($0.18)	($0.64)
FY 2023	20	($4.91)	($1.90)	($3.49)

Global Blood Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/8/2022	Q2 2022	($1.19)	($1.26)	($0.07)	($1.26)	$64.39 million	$71.55 million
5/4/2022	Q1 2022	($1.29)	($1.26)	+$0.03	($1.26)	$56.13 million	$55.20 million
2/23/2022	Q4 2021	($1.14)	($1.36)	($0.22)	($1.36)	$55.45 million	$56.10 million
11/4/2021	9/30/2021	($1.10)	($1.13)	($0.03)	($1.13)	$53.69 million	$52.05 million
8/2/2021	6/30/2021	($1.19)	($1.12)	+$0.07	($1.12)	$43.87 million	$47.56 million
5/4/2021	3/31/2021	($1.01)	($1.21)	($0.20)	($1.21)	$42.88 million	$39.04 million

2/23/2021	12/31/2020	($0.97)	($1.00)	($0.03)	($1.00)	$38.89 million	$41.30 million
11/5/2020	9/30/2020	($0.72)	($0.97)	($0.25)	($0.97)	$44.56 million	$37.00 million
8/5/2020	6/30/2020	($1.18)	($0.86)	+$0.32	($0.86)	$18.85 million	$31.50 million
5/6/2020	3/31/2020	($1.47)	($1.20)	+$0.27	($1.20)	$3.65 million	$14.12 million
2/26/2020	Q4 2019	($1.24)	($1.73)	($0.49)	($1.87)	$0.51 million	$2.11 million
11/7/2019	Q3 2019	($1.03)	($1.07)	($0.04)	($1.07)
8/7/2019	Q2 2019	($0.9610)	($1.01)	($0.0490)	($1.01)
5/8/2019	Q1	($0.9430)	($0.87)	+$0.0730	($0.87)
2/27/2019	Q4 2018	($0.88)	($0.93)	($0.05)	($0.93)
11/6/2018	Q3	($0.85)	($0.83)	+$0.02	($0.83)
8/2/2018	Q2 2018	($0.87)	($0.78)	+$0.09	($0.78)
5/7/2018	Q1 2018	($0.91)	($0.87)	+$0.04	($0.87)
2/27/2018	Q4 2017	($0.7180)	($0.94)	($0.2220)	($0.94)
11/2/2017	Q3 2017	($0.62)	($0.66)	($0.04)	($0.66)
8/7/2017	Q2 2017	($0.61)	($0.55)	+$0.06	($0.55)
5/1/2017	Q1 2017	($0.71)	($0.60)	+$0.11	($0.60)
3/13/2017	Q4 2016	($0.64)	($0.74)	($0.10)	($0.74)
11/9/2016	Q316	($0.58)	($0.58)		($0.58)
8/10/2016	Q216	($0.63)	($0.58)	+$0.05	($0.58)
5/12/2016	Q1	($0.48)	($0.56)	($0.08)	($0.56)
3/29/2016	Q4	($0.6350)	($0.53)	+$0.1050	($0.53)
11/12/2015	Q3 2015	($0.71)	($0.90)	($0.19)	($0.90)
9/24/2015	Q2 2015	($4.04)	($4.84)	($0.80)	($4.84)

Global Blood Therapeutics Earnings - Frequently Asked Questions

How much revenue does Global Blood Therapeutics generate each year?: Global Blood Therapeutics (NASDAQ:GBT) has a recorded annual revenue of $194.75 million.
How much profit does Global Blood Therapeutics generate each year?: Global Blood Therapeutics (NASDAQ:GBT) has a recorded net income of -$303.09 million. GBT has generated -$5.01 earnings per share over the last four quarters.
What is Global Blood Therapeutics's EPS forecast for next year?: Global Blood Therapeutics's earnings are expected to grow from ($4.71) per share to ($3.08) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

Micron Technology (3/28/2023)
BlackRock (4/12/2023)
Infosys (4/12/2023)
Progressive (4/13/2023)
Taiwan Semiconductor Manufacturing (4/13/2023)
UnitedHealth Group (4/13/2023)
U.S. Bancorp (4/13/2023)
Wells Fargo & Company (4/13/2023)
Citigroup (4/14/2023)
JPMorgan Chase & Co. (4/14/2023)

This page (NASDAQ:GBT) was last updated on 3/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Global Blood Therapeutics - GBT Earnings Date, Estimates & Call Transcripts

GBT Earnings Estimates and Actuals by Quarter

GBT Estimated and Actual Revenue by Quarter

Global Blood Therapeutics Analyst Forecasts

Global Blood Therapeutics Earnings History by Quarter

Global Blood Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info